Episode: Dr. Vijayshree Yadav Discusses Complementary and Alternative Medicine for MS


Neurology Today - Neurology Today Podcast Logo
Subscribe
Dr. Vijayshree Yadav Discusses Complementary and Alternative Medicine for MS

Despite the growing number of disease-modifying therapies for multiple sclerosis (MS), a major gap remains when it comes to treatments that are both safe and effective in the long term. So it is no surprise that many MS patients turn to complementary and alternative medicine (CAM) to try to reduce the disease burden. These treatments, however, are not without their own unique risks — especially since CAM is largely unregulated and inadequately studied.

In order to provide guidance to neurologists and their patients, the AAN Guideline Development Subcommittee conducted a comprehensive review of the available literature (from 1970 to 2013) on CAM therapies for MS. The review appeared in the March 25 issue of Neurology.

“The AAN recognized that people with MS tend to use CAM therapy quite frequently, but that there was a lack of scientifically validated information or educational materials for providers to educate themselves or their patients in a systematic way,” said study author Vijayshree Yadav, MD, an assistant professor of neurology at Oregon Health and Sciences University Multiple Sclerosis Center. In an interview with Neurology Today, she discussed the new recommendations — their practical applications, unexpected findings, and remaining research needs.



Neurology Today - Neurology Today Podcast
Users who viewed this episode also viewed...

Neurology Today - Neurology Today Podcast > Dr. Reisa A. Sperling: The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease Trial

What could the findings from the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease trial (A4) — a new secondary prevention trial in older people with amyloid accumulation at high risk for Alzheimer’s disease dementia — mean for Alzheimer’s disease? Earlier detection and possibly earlier intervention, according to the lead author of the A4 trial...

Neurology Today - Neurology Today Podcast > New Data: Could Olfactory Deficits Be Risk Factors for Dementia?

Two new studies presented at the Alzheimer’s Association meeting in Copenhagen found that people in the early stages of Alzheimer’s have subtle deficits in odor identification, a finding that could help diagnose the disease very early on. In this podcast, Neurology Today speaks with Mark Albers, MD, PhD, assistant professor of neurology at Harvard University and a neurologist at Massachusetts General Hospital, and Davangere Devanand, MD, professor of psychiatry at Columbia University Medical Center, about their research...

Neurology Today - Neurology Today Podcast > NINDS Director Story Landis: On Retirement, New Research Directions

Story Landis, PhD, director of the National Institute of Neurological Disorders and Stroke for more than a decade, has announced that she will retire this fall. In this podcast, Dr. Landis speaks with Neurology Today about her groundbreaking work with the NINDS, her decision to retire, and where she believes research in neurology is heading next...
Comments (0)

Login or Sign up to leave a comment.

Log in
Sign up

Be the first to comment.